MedicaNatumin AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 50.89 million compared to SEK 45.86 million a year ago. Net income was SEK 1.6 million compared to SEK 0.037 million a year ago. Basic earnings per share from continuing operations was SEK 0.0043 compared to SEK 0.0001 a year ago. Diluted earnings per share from continuing operations was SEK 0.0043 compared to SEK 0.0001 a year ago. For the nine months, sales was SEK 159.18 million compared to SEK 162.16 million a year ago. Net loss was SEK 15.02 million compared to SEK 3.72 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.0099 a year ago. Diluted loss per share from continuing operations was SEK 0.04 compared to SEK 0.0099 a year ago.